Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > low expectations for tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by Davepark5on Dec 06, 2022 5:38pm

191 Views

Post# 35154646

RE:low expectations for tomorrow

So when will you have high expectations? I have read many of your posts and you have followed this company for a long time. You seem to believe an acquisition is imminent, This runs counter to my experience investing in biotechs where the real excitement seems to happen in pnase III

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario